[Skip to Navigation]
Sign In
March 2017

Supplement 2 Added

JAMA Oncol. 2017;3(3):418. doi:10.1001/jamaoncol.2016.6886

In the Brief Report titled “Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases,”1 published online December 7, 2016, Supplement 2 was omitted when the article was initially published. This article was corrected online.

Priedigkeit  N, Hartmaier  RJ, Chen  Y,  et al.  Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases  [published online December 7, 2016].  JAMA Oncol. doi:10.1001/jamaoncol.2016.5630PubMedGoogle Scholar